Hsp90 Inhibitors,
Part 2: Combining Ligand-Based and
Structure-Based Approaches for Virtual Screening Application

Hsp90 Inhibitors, Part 2: Combining Ligand-Based and Structure-Based Approaches for Virtual Screening Application

Bibliographic Details
Main Authors:	Caroli, Antonia, Ballante, Flavio, Wickersham, Richard B., Corelli, Federico, Ragno, Rino
Format:	Online
Language:	English
Published:	American Chemical Society 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985681/

Similar Items

Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening
by: Jia, JianMin, et al.
Published: (2013)

High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors
by: Davenport, Jason, et al.
Published: (2014)

Spherical Harmonics Coefficients for Ligand-Based Virtual Screening of Cyclooxygenase Inhibitors
by: Wang, Quan, et al.
Published: (2011)

Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors
by: Claribel Murillo-Solano, et al.
Published: (2017-07-01)

Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia
by: Khajapeer, Kalubai Vari, et al.
Published: (2015)

Circumventing HSP90 inhibitors via apoptosis block
by: Fennell, Dean A., et al.
Published: (2015)

Hsp90 Inhibitor Can Inhibit UV-Carcinogenesis
by: Katiyar, Santosh K.
Published: (2015)

Fusing similarity rankings in ligand-based virtual screening
by: Willett, Peter
Published: (2013)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
by: Gillis, Joanna L., et al.
Published: (2013)

Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
by: Woodford, Mark R., et al.
Published: (2016)

Spatiotemporal Regulation of Hsp90–Ligand Complex Leads to Immune Activation
by: Tamura, Yasuaki, et al.
Published: (2016)

The broad stroke of Hsp90 inhibitors: painting over the RAF inhibitor paradox
by: Vido, Michael, et al.
Published: (2015)

Mechanisms of Hsp90 regulation
by: Prodromou, Chrisostomos
Published: (2016)

Best of Both Worlds: On the Complementarity of Ligand-Based and Structure-Based Virtual Screening
by: Broccatelli, Fabio, et al.
Published: (2014)

Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design
by: Chandramohan, Arun, et al.
Published: (2016)

Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.
by: See, Ven Lim, et al.
Published: (2011)

Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus
by: Lim, See Ven, et al.
Published: (2011)

Virtual screening workflow for glycogen synthase kinase 3β inhibitors: convergence of ligand-based and structure-based approaches
by: Palyulin, VA, et al.
Published: (2011)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
by: Wang, Wenqian, et al.
Published: (2016)

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
by: Weigert, Oliver, et al.
Published: (2012)

Identification of the Plant Compound Geraniin as a Novel Hsp90 Inhibitor
by: Vassallo, Antonio, et al.
Published: (2013)

HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates
by: Schulz, Ramona, et al.
Published: (2012)

HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
by: Lai, Chien-Hao, et al.
Published: (2013)

Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
by: Piper, Peter W., et al.
Published: (2011)

Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design
by: Moroni, Elisabetta, et al.
Published: (2012)

Identification of HSP90 inhibitors as a novel class of senolytics
by: Heike Fuhrmann-Stroissnigg, et al.
Published: (2017-09-01)

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
by: Gomez-Casal, Roberto, et al.
Published: (2015)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
by: Fecek, Ronald J, et al.
Published: (2015)

Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells
by: MORI, MASAKI, et al.
Published: (2014)

The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
by: He, Suqin, et al.
Published: (2014)

Heterozygous Yeast Deletion Collection Screens Reveal Essential Targets of Hsp90
by: Franzosa, Eric A., et al.
Published: (2011)

Virtual screening using the ligand ZINC database for novel lipoxygenase-3 inhibitors
by: Monika,, et al.
Published: (2013)

Hsp90 depletion goes wild
by: Siegal, Mark L, et al.
Published: (2012)

Control of Canalization and Evolvability by Hsp90
by: Milton, Claire C., et al.
Published: (2006)

The ‘active life’ of Hsp90 complexes☆
by: Prodromou, Chrisostomos
Published: (2012)

Hsp90, the Concertmaster: Tuning Transcription
by: Khurana, Nidhi, et al.
Published: (2015)

Targeting Hsp90 in urothelial carcinoma
by: Chehab, Mahmoud, et al.
Published: (2015)

Hsp90 Promotes Kinase Evolution
by: Lachowiec, Jennifer, et al.
Published: (2015)

Stability of the Human Hsp90-p50Cdc37 Chaperone Complex against Nucleotides and Hsp90 Inhibitors, and the Influence of Phosphorylation by Casein Kinase 2
by: Olesen, Sanne H., et al.
Published: (2015)

Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
by: Bekki, Hirofumi, et al.
Published: (2015)